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Abstracts of the 12th ISIIH 2S45 
tropicalis; C. glabrata + C. kefyr and those with 3 Candida 
species colonization. 
Conclusions: This casual relationship between prominent 
Candida colonization and adverse impact on short-term 
mortality especially, in patients with hematological cancer 
and BMT recipients was not surprising. High mortality in 
patients with C. glabrata and C. krusei multiple sites 
and/or multiple species colonization was documented. 
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Invasive aspergillosis (IA) is a common fungal infection 
in immunocompromised patients with a high mortality 
rate. We report the case of a 49-year old man with history 
of fever and chills 4 months after kidney transplantation. 
Physical examination and chest radiography were 
normal. Laboratory tests showed CRP elevation (78 
mg/l). Blood cultures and urine bacteriology were sterile. 
Cytomegalovirus-antigenemia negative. Computed 
tomography (CT) of the chest discluded a small nodular 
lesion (1,2 cm) in the left lower lobe. No pathogenic 
organism was identified by bronchoalveolar lavage. 
Serology for toxoplasmosis and cryptococcal antigen 
were negative. Control CT of the chest 2 weeks later 
revealed minimal progression of the pulmonary lesion 
and an in-homogenous enlargement of the thyroid 
gland. Fine needle aspiration of the thyroid revealed 
growth of Aspergillus jumigatus. Inspite of anti-fungal 
therapy with liposomal Amphotericin B the patient 
remained febrile. Echocardiography and MRI of the 
heart showed fibrotic pericarditis and several myocardial 
abscesses, suggesting disseminated IA. Caspofungin and 
flucytosine was added to amphotericin B. Flucytosine 
was stopped after 2 weeks because of leukopenia. 
Three months after the therapy of amphotericin B and 
caspofungin, we observed favourable clinical course, 
regression of the pulmonary lesions and vanishing of the 
myocardial abscesses. The patient was discharged on oral 
itraconazole. In conclusion, we report an unusual clinical 
presentation of invasive aspergillosis with multiple myo- 
cardial abscesses in an immunocompromised patient 
with favourable outcome under experimental antifungal 
combination therapy. 
Yeasts in patients (PTS) with hematologic 
malignaucies (HM) 
N. S. Bagirova and N. I/: Dmitrieva 
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Objectives: To receive a database, which is a basis for 
realization of effective preventive and empiric therapy 
of severe fungal infections in PTS with HM. 
Methods: The monitoring for selection of yeasts from 
different samples (urine, throat, blood, stool and others) 
during 2000-01 was performed. The standard techniques 
of microbiological research were used. The strains were 
identified by the selective medium (CROMagar, Becton 
Dickinson), “Auxacolor” (BIO-RAD) too. Susceptibility 
tests to antifungal drugs (6 agents) were performed with 
“Fungitest” (BIO-RAD). In our study BACTEC 9050 
blood culture system (Becton Dickinson Diagnostic 
instrument Systems) was used (Blood specimens were 
inoculated into BACTEC Mycosis-I(X). 
Results: A total of 590 strains from 294 PTS with HM 
between 2000 and 2001 were obtained. From 316 samples 
fungi were isolated in 8.9 % of cases in association (more 
than one strain from the same sample). 21 positive blood 
cultures from 14 PTS were obtained (only Candida spp., 
64% of them were non-albicans Candida species). There 
were 3 genera of yeasts in our hospital. Among them 
Candida spp, Geotrichum spp., Saccharomyces spp.. 
Candida spp represented 93.7% of all yeast isolates 
(C. albicans - 67.3%, C. glabrata - 8.2%, C. inconspicua 
- 7.0%, C. kefur - 3.1%, C. tropicalis - 2.9%, C. 
parapsilosis - 2.7%) C. krusei - 0.9%, C. lusitaniae - 
0.7%, C. rugosa - 0.4%, C. lipolytica - 0.2%). Non- 
albicans Candida species represented 28.2% of all 
Candida spp. We performed susceptibility tests of yeasts. 
No strain of yeasts was resistant to amphotericin B. 
Susceptibility testing of fungi revealed that the majority 
of the strains were sensitive to fluconazole, itraconazole, 
ketoconazole, miconazole, 5-fluorocytosine. 
Conclusion: The results of this study demonstrate that 
the predominant pathogens were Candida spp.. All 
strains of yeasts were susceptible to amphotericin B. 
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We investigated the in vitro susceptibility of Aspergillus 
fumigatus to 2-d rug combination of amphotericin B lipid 
complex (ABLC) and liposomal amphotericin B (L- 
AMB) with caspofungin (CFG) and micafungin (MFG), 
and the results were compared with those obtained for 
pair-wise combination of conventional amphotericin B 
(C-AMB) with CFG and MFG. Conidial suspensions 
were prepared from 20 clinical isolates of A. fumigatus 
(Microbiology Laboratory, Detroit Medical Center, 
Detroit,Michigan) susceptible to ABLC (MIC 1.26k1.14 
kg/mL), L-AMB (MIC 1.950.87 kg/mL) C-AMB (MIC 
l(O.0 kg/mL), and CFG (MIC 64kO.O kg/mL) and MFG 
(MIC 217.6261.82 kg/mL).The in vitro susceptibility of 
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A. fumigatus to 2-drug combination of ABLC, L-AMB 
or C-AMB with CFG and MFG was evaluated by the 
fractional inhibitory concentration index (FICI) 
method. The FICI was determined by a 2-dimensional 
checker-board using the M38-P broth microdilution 
technique proposed by the National Committee for 
Clinical Laboratory Standards for MIC testing of 
conidium-forming filamentous fungi except that the 
MIC was defined as the concentration of the drug that 
provided no visible growth as determined by the 
reduction of tetrazolium compound (MTT assay). The 
FICI was calculated by the formula: FICI=(A, ( 
A,)+(B,tB ) h a w ere A, and B, are the MICs of drugs A 
and B in combination and A, and B, are the MICs of 
drugs A and B. The drug interactions were classified as 
synergistic (FICI<O.S), additive (FICI>O.S but 11) 
indifferent (FICI>l but 12) and antagonistic (FICI>2). 
The FICIs obtained for six two-drug combinations were 
as follows: AMB+CFG=0.42+0.12, ABLC+CFG= 
0.33+0.15, L-AMB+CFG=0.51+0.10, AMB+MFG= 
0.51r0.11, ABLC +MFG=0.47+0.15 and L-AMB+ 
MFG=0.43 kO.14 indicating synergistic interactions in all 
six combinations. These in vitro data suggest that 
conventional and lipid formulations of amphotericin B in 
2-drug combination with the echinocandin caspofungin or 
micafungin is synergistically active against A. fumigatus. 
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Chronic granulomatous disease (CGD) is a rare in- 
herited disorder of the NADPH oxidase complex 
in which neutrophils and monocytes fail to generate 
reactive oxidants such as superoxide anion and hydrogen 
peroxide, key elements in host defense against a variety 
of bacterial and fungal pathogens. 
The overall incidence of fungal infections in CGD has 
been reported at least 20%, with Aspergillus spp. being 
responsible for 78% of all fungal infections. Aspergillosis 
is the most common cause of mortality in these patients 
being responsible for over one third of deaths. Although 
Aspergillus fumigatus is by far the most frequent fungus 
causing infections in immunocompromised patients, A. 
nidulans has also been recognized as a human pathogen. 
Osteomyelitis has occurred in 25% of patients with 
CGD. Aspergillus spp. are the second most common 
cause accounting for approximately 22% of all osteo- 
myelitis cases as recorded in the USA registry. 
We recently treated a CGD patient with femoral 
osteomyelitis due to A. nidulans who had a favorable 
outcome. We review the reported cases of osteomyelitis 
in CGD patients due to this organism and we compare 
them with those due to A. fumigatus. 
Twenty cases of A. nidulans infections have been 
reported in CGD patients to date. In the great majority, 
lungs have been involved, whereas in some patients, 
expansion to neighboring tissues or to remote areas has 
taken place. Fifteen cases of osteomyelitis due to A. 
nidulans have been described in patients with CGD. All 
of them have been males and associated with simul- 
taneous pulmonary infection except for our case. 
Vertebrae and ribs have been found as the sites most 
commonly affected mainly as a result of rapid con- 
tiguous spread from a pulmonary focus. The outcome 
has been generally poor with a mortality rate approach- 
ing 50%. The commonest genetic pattern has been X- 
linked CGD gp91-phox-deficient (60% of 15 cases). 
The management of these cases has been problematic. 
Treatment has required a combined approach with 
surgical debridement, because of the persistent nature of 
the organism, and administration of intensive and pro- 
longed antifungal therapy with amphotericin-B (AMB) 
in the great majority of cases. The addition of a colony- 
stimulating factor or interferon-gamma has appeared to 
have catalytic role in the treatment of these infections. 
By comparison, osteomyelitis due to A. fumigatus has 
been reported in 8 male CGD patients to date.There has 
been no predilection for particular bones; tibia, femur, 
spine and cranium have been some examples. At least 
two multifocal osteomyelitis cases have been described. 
In all cases the outcome has been favourable. However, 
in most of them treatment has required a combined 
approach with surgical debridement and AMB. In some 
cases, interferon-gamma has also been used. 
In conclusion, overall A. fumigatus has been a more 
common pathogen compared with A. nidulans in CGD, 
but A. nidulans has been more virulent and significantly 
more likely to result in death, to involve adjacent bones 
and to cause disseminated disease compared to A. 
fumigatus. Patients with A. nidulans osteomyelitis have 
received longer courses of AMB therapy compared to 
patients with A. fumigatus osteomyelitis. Surgical 
debridement appears to be necessary, but especially in 
A. nidulans osteomyelitis early surgery is imperative. 
Adjunctive use of cytokines in both A. nidulans and A. 
fimigatus osteomyelitis seems to be successful. This 
comparison shows that A. nidulans osteomyelitis carries 
more severe implications than that of A. fumigatus and 
needs more aggressive therapy. 
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